Resmed (RMD) Free Cash Flow (2009 - 2026)

Resmed's Free Cash Flow history runs 18 years deep, the most recent figure standing at $520.5 million for Q1 2026.

• Quarterly Free Cash Flow fell 6.7% year-over-year to $520.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 billion (up 11.82% YoY) and the FY2025 annual result came in at $1.7 billion, up 27.65% from the prior year.
• Free Cash Flow was $520.5 million for Q1 2026 at Resmed, up from $311.2 million in the prior quarter.
• Across five years, Free Cash Flow topped out at $557.9 million in Q1 2025 and bottomed at $15.6 million in Q3 2022.
• A 5-year average of $288.4 million and a median of $288.0 million in 2024 frame the typical range for Free Cash Flow.
• Annual changes were most pronounced in 2022 — Free Cash Flow tumbled 74.4% — and 2023, when it jumped 1541.98%.
• Resmed's Free Cash Flow stood at $101.3 million in 2022, then surged by 146.31% to $249.5 million in 2023, then gained by 15.43% to $288.0 million in 2024, then rose by 8.07% to $311.2 million in 2025, then surged by 67.25% to $520.5 million in 2026.
• Business Quant data shows RMD's Free Cash Flow at $520.5 million in Q1 2026, $311.2 million in Q4 2025, and $414.4 million in Q3 2025.